BIEL + Electrome + DARPA Electrome’s Technolo
Post# of 8710
(Total Views: 118)
Posted On: 10/09/2025 11:53:32 AM
BIEL + Electrome + DARPA
Electrome’s Technology Electrome is pioneering precision bioelectric therapeutics, using AI to map and modulate cellular behavior with electromagnetic signals. Their platform targets pain, inflammation, infection, and even cancer by tuning bioelectric signals to influence biological responses like angiogenesis, immune modulation, and tissue regeneration.
DARPA’s Interest in Bioelectronics DARPA’s BEST (BioElectronics to Sense and Treat) program is focused on developing smart bandages that use bioelectronic sensors and treatments to monitor and heal battlefield wounds. These devices aim to predict infections and deliver targeted therapies using closed-loop control systems.
Potential Overlap - While there’s no confirmed collaboration between Electrome and DARPA, the technological goals are strikingly aligned:
Both aim to use bioelectric signals for non-invasive, targeted therapies.
Both emphasize real-time monitoring and adaptive treatment.
Both are pushing toward miniaturized, scalable devices for field deployment.
If Electrome’s platform proves scalable and robust, it could be a natural fit for DARPA’s battlefield applications.
Electrome’s Technology Electrome is pioneering precision bioelectric therapeutics, using AI to map and modulate cellular behavior with electromagnetic signals. Their platform targets pain, inflammation, infection, and even cancer by tuning bioelectric signals to influence biological responses like angiogenesis, immune modulation, and tissue regeneration.
DARPA’s Interest in Bioelectronics DARPA’s BEST (BioElectronics to Sense and Treat) program is focused on developing smart bandages that use bioelectronic sensors and treatments to monitor and heal battlefield wounds. These devices aim to predict infections and deliver targeted therapies using closed-loop control systems.
Potential Overlap - While there’s no confirmed collaboration between Electrome and DARPA, the technological goals are strikingly aligned:
Both aim to use bioelectric signals for non-invasive, targeted therapies.
Both emphasize real-time monitoring and adaptive treatment.
Both are pushing toward miniaturized, scalable devices for field deployment.
If Electrome’s platform proves scalable and robust, it could be a natural fit for DARPA’s battlefield applications.
(0)
(0)